Cara Therapeutics (CARA) R&D/CAPEX US GAAP (year values) |
|||||||||
2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
R&D/CAPEX, % | 30 903% | 212 054% | 213 672% | 4 569% | 2 842% | ||||
Changes by years, y/y, % | -601 430pp | +181 151pp | +1 618pp | -213 672pp | -46.4% |
Cara Therapeutics. R&D/CAPEX, %
Cara Therapeutics. R&D/CAPEX, changes, pp
Cara Therapeutics (CARA) R&D/CAPEX US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
R&D/CAPEX, % | 7 880% | 1 383% | 2 626% | 4 432% | 2 842% | |||
Changes by years, y/y, % | ||||||||
Changes by quarters, q/q, % | -7 880pp | +1 243pp | +1 807pp |